表紙:幻覚剤の世界市場の分析 (2022年)
市場調査レポート
商品コード
1107221

幻覚剤の世界市場の分析 (2022年)

Psychedelic Drugs Global Market Report 2022

出版日: 受注後作成 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2~10営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=134.29円
幻覚剤の世界市場の分析 (2022年)
出版日: 受注後作成
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

幻覚剤の世界市場は、2021年の36億2,000万米ドルから2022年には41億9,000万米ドルへ、15.6%のCAGRで成長すると予測されます。幻覚剤市場は14.2%のCAGRで成長し、2026年には70億3,000万米ドルに達すると予測されます。

2021年の幻覚剤市場では、北米が最大の地域となりました。アジア太平洋は予測期間中に最も成長する地域であると予想されます。

精神疾患 (苦痛、PTSDなど) の事例の増加は、今後、幻覚剤市場の成長を促進すると予想されます。精神薬は、うつ病や心的外傷後ストレス障害の治療に使用され、その常用により精神疾患を減少させます。

うつ病向けスプレー薬の登場は、幻覚剤市場で人気を博している主要な動向です。幻覚剤市場で事業を展開する主要企業は、市場での地位を維持するために、大うつ病性障害用の鼻腔スプレー薬を導入しています。

目次

第1章 エグゼクティブサマリー

第2章 幻覚剤市場の特徴

第3章 幻覚剤市場の傾向と戦略

第4章 幻覚剤市場:新型コロナウイルス感染症 (COVID-19) の影響

第5章 幻覚剤市場:市場規模・成長率

  • 過去の市場 (単位:10億米ドル、2016年~2021年)
    • 市場促進要因
    • 市場抑制要因
  • 市場の予測 (単位:10億米ドル、2021年~2026年、2031年)
    • 市場促進要因
    • 市場抑制要因

第6章 幻覚剤市場の内訳

  • 種類別の市場区分 (単位:10億米ドル、2016年~2021年、2021年~2026年、2031年)
    • リゼルギン酸ジエチルアミド (LSD)
    • ケタミン
    • フェンシクリジン
    • ガンマヒドロキシ酪酸 (GHB)
    • サルビア
  • 適応症別の市場区分 (単位:10億米ドル、2016年~2021年、2021年~2026年、2031年)
    • うつ
    • PTSD
  • 原料別の市場区分 (単位:10億米ドル、2016年~2021年、2021年~2026年、2031年)
    • 自然
    • 合成
  • 用途別の市場区分 (単位:10億米ドル、2016年~2021年、2021年~2026年、2031年)
    • 治療抵抗性うつ病
    • アヘン中毒
    • 心的外傷後ストレス障害 (PTSD)
    • ナルコレプシー
    • パニック障害
  • 流通チャネル別の市場区分 (単位:10億米ドル、2016年~2021年、2021年~2026年、2031年)
    • 病院薬局
    • 小売薬局
    • オンライン薬局

第7章 幻覚剤市場:地域別・国別分析

  • 地域別の市場区分 (単位:10億米ドル、2016年~2021年、2021年~2026年、2031年)
  • 国別の市場区分 (単位:10億米ドル、2016年~2021年、2021年~2026年、2031年)

第8章 アジア太平洋の幻覚剤市場

  • 市場概要
  • 地域情報
  • 種類別の市場区分 (単位:10億米ドル、2016年~2021年、2021年~2026年、2031年)
  • 用途別の市場区分 (単位:10億米ドル、2016年~2021年、2021年~2026年、2031年)

第9章 中国の幻覚剤市場

第10章 インドの幻覚剤市場

第11章 日本の幻覚剤市場

第12章 オーストラリアの幻覚剤市場

第13章 インドネシアの幻覚剤市場

第14章 韓国の幻覚剤市場

第15章 西欧の幻覚剤市場

第16章 英国の幻覚剤市場

第17章 ドイツの幻覚剤市場

第18章 フランスの幻覚剤市場

第19章 東欧の幻覚剤市場

第20章 ロシアの幻覚剤市場

第21章 北米の幻覚剤市場

第22章 米国の幻覚剤市場

第23章 南米の幻覚剤市場

第24章 ブラジルの幻覚剤市場

第25章 中東の幻覚剤市場

第26章 アフリカの幻覚剤市場

第27章 幻覚剤市場:競合情勢と企業プロファイル

  • 幻覚剤市場:競合情勢
  • 幻覚剤市場:企業プロファイル
    • Johnson & Johnson
    • Pfizer
    • Hikma Pharmaceuticals PLC
    • Roche Holding AG
    • Merck & Co Inc

第28章 幻覚剤市場における主要な企業合併・買収 (M&A)

第29章 幻覚剤市場:将来展望と潜在力の分析

第30章 付録

目次
Product Code: h1905

“Psychedelic Drugs Global Market Report 2022” from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global psychedelic drugs market.

This report focuses on psychedelic drugs market which is experiencing strong growth. The report gives a guide to the psychedelic drugs market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the psychedelic drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The Psychedelic Drugs market global report” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider psychedelic drugs market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The psychedelic drugs market section of the report gives context. It compares the psychedelic drugs market with other segments of the psychedelic drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, psychedelic drugs indicators comparison.

Scope

Markets Covered:

  • 1) By Type: Lysergic Acid Diethylamid (LSD); Ketamine; Phencyclidine; Gamma Hydroxybutyric Acid (GHB); Salvia
  • 2) By Disease Indication: Depression; PTSD
  • 3) By Origin: Natural; Synthetic
  • 4) By Application: Treatment-Resistant Depression; Opiate addiction; Post- Traumatic Stress Disorder; Narcolepsy; Panic Disorders
  • 5) By Distribution Channel: Hospitals Pharmacy; Retail Pharmacy; Online Pharmacy
  • Companies Mentioned: Johnson & Johnson; Pfizer; Hikma Pharmaceuticals PLC; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Executive Summary

Major players in the psychedelic drug market are: Johnson & Johnson, Pfizer, Hikma Pharmaceuticals PLC, Roche Holding AG, Merck & Co Inc, Jazz Pharmaceuticals plc, COMPASS Pathways PLC, Celon Pharma S.A., Numinus Wellness Inc, AbbVie, Mylan N.V., Avadel, NeuroRx Inc., Klarisana, AstraZeneca, Dr. Reddy's Laboratories Ltd, Takeda Pharmaceutical Company Limited, Allergan Inc, Mota Ventures Corp., Seelos Therapeutics, Emmes Company, and Novatris International AG.

The global psychedelic drugs market is expected to grow from $3.62 billion in 2021 to $4.19 billion in 2022 at a compound annual growth rate (CAGR) of 15.6%. The psychedelic drugs market is expected to reach $7.03 billion in 2026 at a CAGR of 14.2%.

The psychedelic drug market consists of sales of psychedelic drugs by entities (organizations, sole traders, and partnerships) that are used to treat depression and post-traumatic stress disorder and also help with mental health diagnoses. Psychedelic drugs refer to hallucinogens. These drugs are a group of substances that usually alter and enhance perception, thinking processes, energy levels, and promote mental experiences. These include chemicals such as Lysergic acid diethylamid (LSD) and plants such as peyote. These medications are used to treat a variety of brain conditions.

The main types of psychedelic drugs are lysergic acid diethylamid, ketamine, phencyclidine, gamma-hydroxybutyric acid (GHB), and salvia. Lysergic Acid Diethylamide (LSD) is also known colloquially as acid. LSD is manufactured in crystalline form and then mixed with other inert ingredients or diluted as a liquid to produce an ingestible form. The various disease indications include depression and PTSD, which could be natural or synthetic. The numerous applications include treatment-resistant depression, opiate addiction, post-traumatic stress disorder, narcolepsy, and panic disorders, and are distributed through various channels such as hospital pharmacies, retail pharmacies, and online pharmacies.

North America was the largest region in the psychedelic drug market in 2021. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the psychedelic drug market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The psychedelic drugs market research report is one of a series of new reports from The Business Research Company that provides psychedelic drug market statistics, including psychedelic drug industry global market size, regional shares, competitors with a psychedelic drug market share, detailed psychedelic drug market segments, market trends and opportunities, and any further data you may need to thrive in the psychedelic drugs industry. This psychedelic drug market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The increase in the cases of mental illnesses is expected to propel the growth of the psychedelic drug market going forward. Mental illnesses refer to health conditions involving changes in emotion, thinking, or behavior. Mental illnesses include conditions such as distress and post-traumatic stress disorder. Psychedelic drugs are used to treat depression and post-traumatic stress disorder, and their regular usage decreases mental illnesses. For instance, in 2020, according to the National Alliance on Mental Illness (NAMI), a US-based mental health organization, 21% of adults in America were suffering from mental illness in 2020, which amounted to 52.9 million people. Therefore, an increase in the number of cases of mental illnesses is driving the growth of the psychedelic drug market.

The introduction of depression spray is the key trend gaining popularity in the psychedelic drug market. Major companies operating in the psychedelic drug market are introducing nasal-spray drugs for major depressive disorders to sustain their position in the market. For instance, in March 2019, Johnson & Johnson, a US-based company that manufactures psychedelic drugs and pharma medicines, launched a new depression spray named Spravato. The drug acts rapidly on the brain, so it starts working faster than other antidepressants. It works by restoring brain cells in patients with treatment-resistant depression.

In April 2022, Numinus, a Canada-based company that manufactures psychedelic medicine with holistic, integrated psychotherapy, acquired Novamind for a deal amount of $20.77 million. With this acquisition, Numinus is expected to expand its psychotherapy clinics in the US and develop advanced psychedelic programs. Novamind is a US-based mental health company and manufacturer of psychedelic medicine.

The countries covered in the psychedelic drug market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Table of Contents

1. Executive Summary

2. Psychedelic Drugs Market Characteristics

3. Psychedelic Drugs Market Trends And Strategies

4. Impact Of COVID-19 On Psychedelic Drugs

5. Psychedelic Drugs Market Size And Growth

  • 5.1. Global Psychedelic Drugs Historic Market, 2016-2021, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Psychedelic Drugs Forecast Market, 2021-2026F, 2031F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Psychedelic Drugs Market Segmentation

  • 6.1. Global Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Lysergic Acid Diethylamid (LSD)
  • Ketamine
  • Phencyclidine
  • Gamma Hydroxybutyric Acid (GHB)
  • Salvia
  • 6.2. Global Psychedelic Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Depression
  • PTSD
  • 6.3. Global Psychedelic Drugs Market, Segmentation By Origin, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Natural
  • Synthetic
  • 6.4. Global Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Treatment Resistant depression
  • Opiate addiction
  • Post- Traumatic stress disorder
  • Narcolepsy
  • Panic Disorders
  • 6.5. Global Psychedelic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Hospitals Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

7. Psychedelic Drugs Market Regional And Country Analysis

  • 7.1. Global Psychedelic Drugs Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 7.2. Global Psychedelic Drugs Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

8. Asia-Pacific Psychedelic Drugs Market

  • 8.1. Asia-Pacific Psychedelic Drugs Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 8.3. Asia-Pacific Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

9. China Psychedelic Drugs Market

  • 9.1. China Psychedelic Drugs Market Overview
  • 9.2. China Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion
  • 9.3. China Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

10. India Psychedelic Drugs Market

  • 10.1. India Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 10.2. India Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

11. Japan Psychedelic Drugs Market

  • 11.1. Japan Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 11.2. Japan Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

12. Australia Psychedelic Drugs Market

  • 12.1. Australia Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 12.2. Australia Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

13. Indonesia Psychedelic Drugs Market

  • 13.1. Indonesia Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 13.2. Indonesia Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

14. South Korea Psychedelic Drugs Market

  • 14.1. South Korea Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 14.2. South Korea Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

15. Western Europe Psychedelic Drugs Market

  • 15.1. Western Europe Psychedelic Drugs Market Overview
  • 15.2. Western Europe Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 15.3. Western Europe Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

16. UK Psychedelic Drugs Market

  • 16.1. UK Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 16.2. UK Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

17. Germany Psychedelic Drugs Market

  • 17.1. Germany Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 17.2. Germany Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

18. France Psychedelic Drugs Market

  • 18.1. France Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 18.2. France Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

19. Eastern Europe Psychedelic Drugs Market

  • 19.1. Eastern Europe Psychedelic Drugs Market Overview
  • 19.2. Eastern Europe Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 19.3. Eastern Europe Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

20. Russia Psychedelic Drugs Market

  • 20.1. Russia Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 20.2. Russia Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

21. North America Psychedelic Drugs Market

  • 21.1. North America Psychedelic Drugs Market Overview
  • 21.2. North America Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 21.3. North America Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

22. USA Psychedelic Drugs Market

  • 22.1. USA Psychedelic Drugs Market Overview
  • 22.2. USA Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 22.3. USA Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

23. South America Psychedelic Drugs Market

  • 23.1. South America Psychedelic Drugs Market Overview
  • 23.2. South America Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 23.3. South America Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

24. Brazil Psychedelic Drugs Market

  • 24.1. Brazil Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 24.2. Brazil Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

25. Middle East Psychedelic Drugs Market

  • 25.1. Middle East Psychedelic Drugs Market Overview
  • 25.2. Middle East Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 25.3. Middle East Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

26. Africa Psychedelic Drugs Market

  • 26.1. Africa Psychedelic Drugs Market Overview
  • 26.2. Africa Psychedelic Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 26.3. Africa Psychedelic Drugs Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

27. Psychedelic Drugs Market Competitive Landscape And Company Profiles

  • 27.1. Psychedelic Drugs Market Competitive Landscape
  • 27.2. Psychedelic Drugs Market Company Profiles
    • 27.2.1. Johnson & Johnson
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Pfizer
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Hikma Pharmaceuticals PLC
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Roche Holding AG
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Merck & Co Inc
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Psychedelic Drugs Market

29. Psychedelic Drugs Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Research Inquiries
  • 30.4. The Business Research Company
  • 30.5. Copyright And Disclaimer